The global veterinary medicine market size is expected to reach USD 50.8 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.4% from 2021 to 2028. The companion animal segment is anticipated to demonstrate the fastest growth during the forecast period owing to the increasing prevalence of chronic diseases and rising demand for advanced treatment alternatives for canines suffering from chronic diseases.
COVID19 pandemic resulted in to regulatory changes which are anticipated to iron out the disruptions thereby increasing manufacturing and adoption of vet medicines in near future. The federal government has taken various relief measures which include new tax provisions, small business loans and unemployment insurance in order to respond to the pandemic and support the veterinarians. AVMA has also taken supportive measures to support small veterinary businesses or practices. In August 2020 USFDA stated that, 6 out of 32 animal drug companies who source their API from China could soon face shortages. Due to labor shortage, there is also reduced capacity to work on animal health activities such as vaccination, good biosecurity and prophylactic treatment. The manufacturing units are taking preventive measures for uninterrupted production of veterinary drugs.
Growing consumption of meat is fueling the demand for mandatory vaccination for animals, which results in the market growth. According to The World Counts, Denmark, the global meat production has increased 2-fold from 1988 to 2018. It also stated that meat consumption is estimated to range between 460 – 570 million tons by 2050. Such factors are expected to drive the growth of the market during the forecast period.
The market leaders are involved in strategic collaborations, regional expansion, and new product launch to sustain the competition. For instance, in Elanco acquired Bayer’s animal health division in August 2020 in an attempt to strengthen its R&D capabilities, eCommerce presence, and multiply its product portfolio. Additionally, in March 2020, Virbac signed an agreement with Pebble Labs for co-development and commercialization of products for disease prevention in aquatic animals.
Browse full report with Table of Content @ https://www.grandviewresearch.com/industry-analysis/veterinary-medicine-market
Veterinary Medicine Market Report Highlights
The production animal segment dominated the overall revenues share as of 2020 and is projected to show a CAGR of over 7.3% from 2021 to 2028. Increasing focus on food safety and sustainability by government healthcare organizations globally is contributing to market growth
North America held a major market share as of 2020, due to the high prevalence of zoonotic diseases in this region. Moreover, reimbursement programs across the U.S. make this continent a major contributor to the market
Europe held the second largest market share owing to the favorable government regulations such as the EU Veterinary Medicines Regulation and high number of insured pets in the Western European countries
The industry participants are focusing on strategic collaborations, acquisitions, investing in new product segments, mergers, and new product launches to gain a competitive edge in the market
Some of the leading players are expected to maintain their market position during the forecast period in terms of product penetration, regional presence, revenue, as well as strategic initiatives
The biologics segment which includes vaccines and other such products is expected to exhibit the fastest growth over the forecast period owing to the increasing awareness regarding important of vaccination in animals
The oral mode of administration is expected to grow at the fastest growth rate owing to the increasing incidence of chronic conditions in pets
The reference laboratories held a considerable market share of about 9% in 2020 in the market as the laboratories enable testing of various infections, toxic agents, and different ailments in specimens obtained from pets
Asia Pacific is anticipated to witness lucrative growth of around 8.0% owing to increasing adoption of pet animals, growing health concerns about the animals, and rising prevalence of diseases in animals
For Requesting a Sample Copy of This Report, Please Visit @ https://www.grandviewresearch.com/industry-analysis/veterinary-medicine-market/request/rs1
Veterinary Medicine Market Segmentation
Grand View Research has segmented the global veterinary medicine market on the basis of animal type, product, mode of delivery, end use, and region:
Veterinary Medicine Animal Type Outlook (Revenue, USD Million, 2016 – 2028)
Sheep & Goats
Veterinary Medicine Product Outlook (Revenue, USD Million, 2016 – 2028)
Live attenuated vaccines
Medicated Feed Additives
Veterinary Medicine Mode of Delivery Outlook (Revenue, USD Million, 2016 – 2028)
Others (Topical, carrier)
Veterinary Medicine End-use Outlook (Revenue, USD Million, 2016 – 2028)
Point-of-care testing/In-house testing
Veterinary Hospitals & Clinics
Veterinary Medicine Regional Outlook (Revenue, USD Million, 2016 – 2028)
Middle East & Africa
List of Key Players of Veterinary Medicine Market
Merck Animal Health
Ceva Sante Animale
Boehringer Ingelheim GmbH
Kindred Biosciences, Inc.
Indian Immunologicals Ltd
Philbro Animal Health
Inquire more or share questions if any before the purchase on this report @ https://www.grandviewresearch.com/inquiry/6782/ibb
Browse More Related Report:
Veterinary Care Market Size, Share & Trends Analysis Report By Type Of Care (Primary, Critical), By Animal Type (Companion, Production), By Region (North America, APAC), And Segment Forecasts, 2021 – 2028
About Grand View Research
Grand View Research is a full-time market research and consulting company registered in San Francisco, California. The company fully offers market reports, both customized and syndicates, based on intense data analysis. It also offers consulting services to business communities and academic institutions and helps them understand the global and business scenario to a significant extent. The company operates across multitude of domains such as Chemicals, Materials, Food and Beverages, Consumer Goods, Healthcare, and Information Technology to offer consulting services.
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Address:Grand View Research, Inc. 201 Spear Street 1100 San Francisco, CA 94105, United States
City: San Francisco
Country: United States